{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:04:39Z","timestamp":1790363079324,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T00:00:00Z","timestamp":1479254400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0374-2","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T07:57:45Z","timestamp":1479283065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Paediatric Fabry disease: prognostic significance of ocular changes for disease severity"],"prefix":"10.1186","volume":"16","author":[{"given":"Gisela","family":"Kalkum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Karabul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Pintos-Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Bizjajeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Ramaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"issue":"2","key":"374_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ymgme.2009.10.027","volume":"99","author":"M Banikazemi","year":"2010","unstructured":"Banikazemi M, Patel M, Lemay R, Waldek S. Life expectancy and cause of death in Fabry disease: findings from the Fabry Registry. Mol Genet Metab. 2010;99(2):S10.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"374_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet. 2001;38(11):769\u201375.","journal-title":"J Med Genet"},{"issue":"11","key":"374_CR3","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet. 2001;38(11):750\u201360.","journal-title":"J Med Genet"},{"issue":"11","key":"374_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med. 2009;11(11):790\u20136.","journal-title":"Genet Med"},{"issue":"1","key":"374_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1651-2227.2007.00029.x","volume":"96","author":"U Ramaswami","year":"2007","unstructured":"Ramaswami U, Wendt S, Pintos-Morell G, Parini R, Whybra C, Leon Leal JA, et al. Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta Paediatr. 2007;96(1):122\u20137.","journal-title":"Acta Paediatr"},{"issue":"1","key":"374_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/08035250500275022","volume":"95","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U, Whybra C, Parini R, Pintos-Morell G, Mehta A, Sunder-Plassmann G, et al. Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey. Acta Paediatr. 2006;95(1):86\u201392.","journal-title":"Acta Paediatr"},{"issue":"3","key":"374_CR7","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1542\/peds.2004-1678","volume":"115","author":"M Ries","year":"2005","unstructured":"Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GJ, et al. Pediatric Fabry disease. Pediatrics. 2005;115(3):e344\u201355.","journal-title":"Pediatrics"},{"issue":"11","key":"374_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","volume":"162","author":"M Ries","year":"2003","unstructured":"Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, et al. The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr. 2003;162(11):767\u201372.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"374_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.optm.2010.02.011","volume":"81","author":"AM Morier","year":"2010","unstructured":"Morier AM, Minteer J, Tyszko R, McCann R, Clarke MV, Browning MF. Ocular manifestations of Fabry disease within in a single kindred. Optometry. 2010;81(9):437\u201349.","journal-title":"Optometry"},{"issue":"4","key":"374_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan PB, Baehner AF, Barba Romero MA, Hughes DA, Kampmann C, Beck M. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet. 2006;43(4):347\u201352.","journal-title":"J Med Genet"},{"issue":"3","key":"374_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, de Lorenzo Garcia A, Kampmann C, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34(3):236\u201342.","journal-title":"Eur J Clin Invest"},{"issue":"5 Suppl","key":"374_CR12","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","volume":"144","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatr. 2004;144(5 Suppl):S20\u20136.","journal-title":"J Pediatr"},{"key":"374_CR13","first-page":"305","volume-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"U Ramaswami","year":"2006","unstructured":"Ramaswami U, Parini R, Pintos-Morell G. Natural history and effects of enzyme replacement therapy in children and adolescents with Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford, UK: Oxford PharmaGenesis Ltd; 2006. p. 305\u201313."},{"issue":"4","key":"374_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","volume":"53","author":"N Samiy","year":"2008","unstructured":"Samiy N. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder. Surv Ophthalmol. 2008;53(4):416\u201323.","journal-title":"Surv Ophthalmol"},{"key":"374_CR15","doi-asserted-by":"crossref","unstructured":"van der Tol L, Sminia ML, Hollak CE, Biegstraaten M. Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review. Br J Ophthalmol. 2016;100(1):3\u20138.","DOI":"10.1136\/bjophthalmol-2014-306433"},{"issue":"6","key":"374_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1755-3768.1984.tb08444.x","volume":"62","author":"A Tsutsumi","year":"1984","unstructured":"Tsutsumi A, Uchida Y, Kanai T, Tsutsumi O, Satoh K, Sakamoto S. Corneal findings in a foetus with Fabry's disease. Acta Ophthalmol (Copenh). 1984;62(6):923\u201331.","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"374_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","volume":"97","author":"NA Sher","year":"1979","unstructured":"Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry's disease. Arch Ophthalmol. 1979;97(4):671\u20136.","journal-title":"Arch Ophthalmol"},{"key":"374_CR18","first-page":"249","volume-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"A Sodi","year":"2006","unstructured":"Sodi A, Ioannidis A, Pitz S. Ophthalmological manifestations of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford, UK: Oxford PharmaGenesis Ltd; 2006. p. 249\u201361."},{"key":"374_CR19","doi-asserted-by":"publisher","first-page":"207573","DOI":"10.1155\/2013\/207573","volume":"2013","author":"L Michaud","year":"2013","unstructured":"Michaud L. Vascular tortuosities of the upper eyelid: a new clinical finding in fabry patient screening. J Ophthalmol. 2013;2013:207573.","journal-title":"J Ophthalmol"},{"issue":"5","key":"374_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0039-6257(82)90159-X","volume":"26","author":"EM Riegel","year":"1982","unstructured":"Riegel EM, Pokorny KS, Friedman AH, Suhan J, Ritch RH, Desnick RJ. Ocular pathology of Fabry's disease in a hemizygous male following renal transplantation. Surv Ophthalmol. 1982;26(5):247\u201352.","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"374_CR21","first-page":"599","volume":"154","author":"H Witschel","year":"1969","unstructured":"Witschel H, Mathyl J. Morphological bases of the specific ocular changes in Fabry\u2019s disease [in German]. Klin Monatsbl Augenheilkd. 1969;154(4):599\u2013605.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"5","key":"374_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0022-3476(74)80019-3","volume":"84","author":"C Borrone","year":"1974","unstructured":"Borrone C, Gatti R, Trias X, Durand P. Fucosidosis: clinical, biochemical, immunologic, and genetic studies in two new cases. J Pediatr. 1974;84(5):727\u201330.","journal-title":"J Pediatr"},{"issue":"7","key":"374_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/bjo.60.7.508","volume":"60","author":"MB Snodgrass","year":"1976","unstructured":"Snodgrass MB. Ocular findings in a case of fucosidosis. Br J Ophthalmol. 1976;60(7):508\u201311.","journal-title":"Br J Ophthalmol"},{"key":"374_CR24","volume-title":"Duane's Clinical Ophthalmology","author":"S Al-Hazzaa","year":"2006","unstructured":"Al-Hazzaa S, Ozand P, Traboulsi EI. Metabolic diseases and the eye. In: Tasman W, Jaeger EA, editors. Duane's Clinical Ophthalmology. Volume 5. Philadelphia: Lippincott Williams & Wilkins; 2006. Chapter 19.","edition":"Volume 5"},{"issue":"2","key":"374_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0022-3476(69)80387-2","volume":"75","author":"J O'Brien","year":"1969","unstructured":"O'Brien J. Generalized gangliosidosis. J Pediatr. 1969;75(2):167\u201386.","journal-title":"J Pediatr"},{"issue":"4","key":"374_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00417-008-0962-9","volume":"247","author":"K Falke","year":"2009","unstructured":"Falke K, Buttner A, Schittkowski M, Stachs O, Kraak R, Zhivov A, et al. The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study. Graefes Arch Clin Exp Ophthalmol. 2009;247(4):523\u201334.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"374_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0002-9394(68)92796-7","volume":"66","author":"CA Burns","year":"1968","unstructured":"Burns CA. Indomethacin, reduced retinal sensitivity, and corneal deposits. Am J Ophthalmol. 1968;66(5):825\u201335.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"374_CR28","first-page":"294","volume":"12","author":"JC Yam","year":"2006","unstructured":"Yam JC, Kwok AK. Ocular toxicity of hydroxychloroquine. Hong Kong Med J. 2006;12(4):294\u2013304.","journal-title":"Hong Kong Med J"},{"issue":"3","key":"374_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0002-9394(76)90496-7","volume":"82","author":"AI Arbisser","year":"1976","unstructured":"Arbisser AI, Murphree AL, Garcia CA, Howell RR. Ocular findings in mannosidosis. Am J Ophthalmol. 1976;82(3):465\u201371.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"374_CR30","doi-asserted-by":"publisher","first-page":"e0120814","DOI":"10.1371\/journal.pone.0120814","volume":"10","author":"C Pitz","year":"2015","unstructured":"Pitz C, Kalkum G, Arash L, Karabul N, Sodi A, Larroque S, et al. Ocular signs correlate well with disease severity and genotype in Fabry disease. PLoS One. 2015;10(3):e0120814.","journal-title":"PLoS One"},{"issue":"447","key":"374_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/08035320510031045","volume":"94","author":"E Schaefer","year":"2005","unstructured":"Schaefer E, Mehta A, Gal A. Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatr Suppl. 2005;94(447):87\u201392; discussion 79.","journal-title":"Acta Paediatr Suppl"},{"key":"374_CR32","first-page":"315","volume-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"C Whybra","year":"2006","unstructured":"Whybra C, Bahner F, Baron K. Measurement of disease severity and progression in Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry Disease: Perspectives from 5 Years of FOS. Oxford, UK: Oxford PharmaGenesis Ltd; 2006. p. 315\u201322."},{"issue":"2-3","key":"374_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymgme.2010.06.002","volume":"101","author":"DA Hughes","year":"2010","unstructured":"Hughes DA, Ramaswami U, Barba Romero MA, Deegan P. Age adjusting severity scores for Anderson-Fabry disease. Mol Genet Metab. 2010;101(2-3):219\u201327.","journal-title":"Mol Genet Metab"},{"key":"374_CR34","unstructured":"Gal A, Larroque S, Mehta A. Fabry disease: clinical severity correlates with gene mutation. Presented at: Annual Symposium of the Society for the Study of Inborn Errors of Metabolism: September 4\u20137 2012; Birmingham, UK; 2012."},{"issue":"12","key":"374_CR35","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1136\/bjo.2009.176651","volume":"94","author":"LE Allen","year":"2010","unstructured":"Allen LE, Cosgrave EM, Kersey JP, Ramaswami U. Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity. Br J Ophthalmol. 2010;94(12):1602\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"374_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjo.2006.100602","volume":"91","author":"A Sodi","year":"2007","unstructured":"Sodi A, Ioannidis AS, Mehta A, Davey C, Beck M, Pitz S. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey. Br J Ophthalmol. 2007;91(2):210\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"374_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","volume":"33","author":"TT Nguyen","year":"2005","unstructured":"Nguyen TT, Gin T, Nicholls K, Low M, Galanos J, Crawford A. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Experiment Ophthalmol. 2005;33(2):164\u20138.","journal-title":"Clin Experiment Ophthalmol"},{"key":"374_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1477-7525-10-116","volume":"10","author":"U Ramaswami","year":"2012","unstructured":"Ramaswami U, Stull DE, Parini R, Pintos-Morell G, Whybra C, Kalkum G, et al. Measuring patient experiences in Fabry disease: validation of the Fabry-specific Pediatric Health and Pain Questionnaire (FPHPQ). Health Qual Life Outcomes. 2012;10:116.","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-016-0374-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0374-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:40:17Z","timestamp":1498347617000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-016-0374-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["374"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0374-2","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]},"article-number":"202"}}